Name | 2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzamide |
---|---|
Synonyms | 2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
Description | Gefitinib impurity 2 is the impurity of Gefitinib. Gefitinib (ZD1839; HY-50895) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity[1][2]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C15H23N3O4 |
---|---|
Molecular Weight | 309.36100 |
Exact Mass | 309.16900 |
PSA | 101.03000 |
LogP | 1.88070 |
Precursor 7 | |
---|---|
DownStream 3 | |